These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk of zoonosis in xenotransplantation. Takeuchi Y Transplant Proc; 2000 Dec; 32(8):2698-700. PubMed ID: 11134767 [No Abstract] [Full Text] [Related]
3. No evidence of PERV infection in healthcare workers exposed to transgenic porcine liver extracorporeal support. Levy MF; Argaw T; Wilson CA; Brooks J; Sandstrom P; Merks H; Logan J; Klintmalm G Xenotransplantation; 2007 Jul; 14(4):309-15. PubMed ID: 17669172 [TBL] [Abstract][Full Text] [Related]
4. [Porcine endogenous retroviruses (PERVs) and xenotransplantation. A risk for the recipient and for society?]. Specke V; Denner J Dtsch Med Wochenschr; 2003 Jun; 128(23):1301-6. PubMed ID: 12789643 [No Abstract] [Full Text] [Related]
6. A CRISPR Way to Block PERVs--Engineering Organs for Transplantation. Salomon DR N Engl J Med; 2016 Mar; 374(11):1089-91. PubMed ID: 26981939 [No Abstract] [Full Text] [Related]
7. Porcine endogenous retroviruses (PERVs): adaptation to human cells and attempts to infect small animals and non-human primates. Denner J; Specke V; Schwendemann J; Tacke SJ Ann Transplant; 2001; 6(3):25-33. PubMed ID: 11899894 [No Abstract] [Full Text] [Related]
8. Possible transmission of zoonoses in xenotransplantation: porcine endogenous retroviruses (PERVs) from an immunological point of view. Schmidt P; Andersson G; Blomberg J; Malmsten A; Korsgren O Acta Vet Scand Suppl; 2004; 99():27-34. PubMed ID: 15347144 [No Abstract] [Full Text] [Related]
9. Porcine endogenous retrovirus does not infect human cells using a bioartificial liver model system. Falasca E; Adami V; Astori G; Donini A; Biffoni F; Degrassi A; Botta GA; Pipan C Transplant Proc; 2001; 33(1-2):1780-1. PubMed ID: 11267509 [No Abstract] [Full Text] [Related]
10. Bioartificial organs may help reduce risk of zoonosis in xenotransplantation. Mullon C Artif Organs; 1999 Apr; 23(4):366-7. PubMed ID: 10226702 [No Abstract] [Full Text] [Related]
11. "Xenoassistance devices" for the treatment of hepatic failure: challenges and controversies. Platt JL Transplant Proc; 2000 Dec; 32(8):2693-5. PubMed ID: 11134765 [No Abstract] [Full Text] [Related]
13. 7th Congress of the International Xenotransplantation Association. McKenzie IF Xenotransplantation; 2004 May; 11(3):230-2. PubMed ID: 15099201 [No Abstract] [Full Text] [Related]
14. Getting rid of PERVs. Jarchum I Nat Biotechnol; 2016 Jan; 34(1):46. PubMed ID: 26744982 [No Abstract] [Full Text] [Related]
15. Prospects for the temporary treatment of acute liver failure. Stockmann HB; IJzermans JN Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):195-203. PubMed ID: 11981346 [TBL] [Abstract][Full Text] [Related]
17. Xenotransplantation: reappraising the risk of retroviral zoonosis. Takeuchi Y; Weiss RA Curr Opin Immunol; 2000 Oct; 12(5):504-7. PubMed ID: 11007351 [No Abstract] [Full Text] [Related]
18. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Yang L; Güell M; Niu D; George H; Lesha E; Grishin D; Aach J; Shrock E; Xu W; Poci J; Cortazio R; Wilkinson RA; Fishman JA; Church G Science; 2015 Nov; 350(6264):1101-4. PubMed ID: 26456528 [TBL] [Abstract][Full Text] [Related]
19. Paving the Path toward Porcine Organs for Transplantation. Denner J N Engl J Med; 2017 Nov; 377(19):1891-1893. PubMed ID: 29117497 [No Abstract] [Full Text] [Related]
20. Seventh Congress of the International Xenotransplantation Association (IXA), Glasgow, 2003: "in vitro" highlights. Breimer ME Xenotransplantation; 2004 May; 11(3):226-7. PubMed ID: 15099199 [No Abstract] [Full Text] [Related] [Next] [New Search]